Navigate BioPharma Services, Inc.
Mark Blimline is a Senior Scientist at Navigate BioPharma Services, Inc. since October 2018, with prior experience as a Scientist III at BioAgilytix Labs and Senior Research Associate at Applied Proteomics, Inc. Demonstrated expertise includes the development and validation of assays for clinical studies, management of multi-disciplinary teams, and training in laboratory practices. Academic credentials include a Master of Science in Integrative Physiology and a Bachelor of Arts in Molecular Cellular and Developmental Biology from the University of Colorado Boulder. Previous roles also encompassed project oversight at Intertek, and research assistance at the University of Utah, University of Colorado Boulder, and University of Hawaii at Manoa.
Navigate BioPharma Services, Inc.
Navigate BioPharma is a specialty laboratory offering high quality, innovative and differentiated precision medicine solutions for drug development and diagnostic applications. We enable innovative treatments through integrated laboratory services to improve and expedite the clinical trial process—aiming to increase your probability of success. We take on complex issues, utilizing our deep scientific knowledge, diversity of experience, adaptability and regulatory success to design customized offerings that help bring new treatments to market faster. Our deep scientific knowledge in diagnosis, disease monitoring and the #immunotherapy field—including #cart #celltherapy— gets our clients the data they need. With end-to-end services customized for each client, we take a consultative and comprehensive approach to deliver accurate and actionable information in an effort to improve treatment outlook for clinical trial subjects. #bioanalysis #bioanalytical #biomarker #immunooncology #biopharma #drugdevelopment *Navigate BioPharma is an independent subsidiary of Novartis.